JAGSONPAL PHARMACEUTICALS LTD.
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹413.65
- Today's High:
- ₹475
- Open Price:
- ₹419.15
- 52W Low:
- ₹280.15
- 52W High:
- ₹420.2
- Prev. Close:
- ₹419.95
- Volume:
- 74789
Company Statistics
- Market Cap.:
- ₹9.78 billion
- Book Value:
- 60.69
- Revenue TTM:
- ₹2.37 billion
- Operating Margin TTM:
- 13.92%
- Gross Profit TTM:
- ₹1.30 billion
- Profit Margin:
- 11.29%
- Return on Assets TTM:
- 11.33%
- Return on Equity TTM:
- 18.45%
Company Profile
JAGSONPAL PHARMACEUTICALS LTD. had its IPO on under the ticker symbol JAGSNPHARM.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. JAGSONPAL PHARMACEUTICALS LTD. has a staff strength of 0 employees.
Stock update
Shares of JAGSONPAL PHARMACEUTICALS LTD. opened at ₹419.15 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹413.65 - ₹475, and closed at ₹437.3.
This is a +4.13% increase from the previous day's closing price.
A total volume of 74,789 shares were traded at the close of the day’s session.
In the last one week, shares of JAGSONPAL PHARMACEUTICALS LTD. have increased by +5.16%.
JAGSONPAL PHARMACEUTICALS LTD.'s Key Ratios
JAGSONPAL PHARMACEUTICALS LTD. has a market cap of ₹9.78 billion, indicating a price to book ratio of 6.8826 and a price to sales ratio of 4.05.
In the last 12-months JAGSONPAL PHARMACEUTICALS LTD.’s revenue was ₹2.37 billion with a gross profit of ₹1.30 billion and an EBITDA of ₹341.52 million. The EBITDA ratio measures JAGSONPAL PHARMACEUTICALS LTD.'s overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, JAGSONPAL PHARMACEUTICALS LTD.’s operating margin was 13.92% while its return on assets stood at 11.33% with a return of equity of 18.45%.
In Q1, JAGSONPAL PHARMACEUTICALS LTD.’s quarterly earnings growth was a positive 21300% while revenue growth was a positive 6.4%.
JAGSONPAL PHARMACEUTICALS LTD.’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 36.2124
- PEG
Its diluted EPS in the last 12-months stands at ₹10.31 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into JAGSONPAL PHARMACEUTICALS LTD.’s profitability.
JAGSONPAL PHARMACEUTICALS LTD. stock is trading at a EV to sales ratio of 3.8197 and a EV to EBITDA ratio of 32.3563. Its price to sales ratio in the trailing 12-months stood at 4.05.
JAGSONPAL PHARMACEUTICALS LTD. stock pays annual dividends of ₹5 per share, indicating a yield of 1.36% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹1.95 billion
- Total Liabilities
- ₹275.72 million
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
JAGSONPAL PHARMACEUTICALS LTD. ended 2024 with ₹1.95 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.95 billion while shareholder equity stood at ₹1.59 billion.
JAGSONPAL PHARMACEUTICALS LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹275.72 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0.00 in goodwill. Its cash balance stood at ₹110.53 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
JAGSONPAL PHARMACEUTICALS LTD.’s total current assets stands at ₹1.65 billion while long-term investments were ₹0 and short-term investments were ₹1.04 billion. Its net receivables were ₹208.72 million compared to accounts payable of ₹163.63 million and inventory worth ₹206.76 million.
In 2024, JAGSONPAL PHARMACEUTICALS LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, JAGSONPAL PHARMACEUTICALS LTD. paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹437.3
- 52-Week High
- ₹420.2
- 52-Week Low
- ₹280.15
- Analyst Target Price
- ₹
JAGSONPAL PHARMACEUTICALS LTD. stock is currently trading at ₹437.3 per share. It touched a 52-week high of ₹420.2 and a 52-week low of ₹420.2. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹414.74 and 200-day moving average was ₹359.43 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7841.8% of the company’s stock are held by insiders while 9.8% are held by institutions.
Frequently Asked Questions About JAGSONPAL PHARMACEUTICALS LTD.
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Jagsonpal Pharmaceuticals Limited develops and manufactures bulk drugs and pharmaceutical formulations in the areas of women health, pain and analgesics, and general medicine. It offers general medicines, such as allergy management, immunity and cell protection, gut and mind management, anti-infectives, and dentist and ENT range products; and women’s healthcare products, including pregnancy care, and dysfunctional uterine bleeding complications and management products. The company also provides pain and analgesics products in the areas of pain management, and bone and joint care. It offers drugs in the form of tablets, capsules, and syrups. The company was founded in 1964 and is headquartered in New Delhi, India. Jagsonpal Pharmaceuticals Limited is a subsidiary of Aresko Progressive Private Limited.